276
Participants
Start Date
April 22, 2022
Primary Completion Date
July 30, 2024
Study Completion Date
August 27, 2024
Depemokimab (GSK3511294)
Depemokimab (GSK3511294) will be administered using a pre- filled syringe.
Placebo
Placebo will be administered as normal saline using a pre-filled syringe.
GSK Investigational Site, Buenos Aires
GSK Investigational Site, La Plata
GSK Investigational Site, Mendoza
GSK Investigational Site, Mar del Plata
GSK Investigational Site, Ghent
GSK Investigational Site, Great Neck
GSK Investigational Site, Jerez de la Frontera
GSK Investigational Site, Marseille
GSK Investigational Site, Rochester
GSK Investigational Site, La Rochelle
GSK Investigational Site, Bethlehem
GSK Investigational Site, Richmond
GSK Investigational Site, Chapel Hill
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Pamplona
GSK Investigational Site, Toulouse
GSK Investigational Site, Gainesville
GSK Investigational Site, Tamarac
GSK Investigational Site, Tampa
GSK Investigational Site, Montpellier
GSK Investigational Site, Marburg
GSK Investigational Site, Grenoble
GSK Investigational Site, Louisville
GSK Investigational Site, Düsseldorf
GSK Investigational Site, Lexington
GSK Investigational Site, Düsseldorf
GSK Investigational Site, Seville
GSK Investigational Site, Nantes
GSK Investigational Site, Dortmund
GSK Investigational Site, Cincinnati
GSK Investigational Site, Valladolid
GSK Investigational Site, Münster
GSK Investigational Site, Zaragoza
GSK Investigational Site, Bonn
GSK Investigational Site, Valenciennes
GSK Investigational Site, Chicago
GSK Investigational Site, Clermont-Ferrand
GSK Investigational Site, Wiesbaden
GSK Investigational Site, Tulsa
GSK Investigational Site, Aurora
GSK Investigational Site, München
GSK Investigational Site, Meridian
GSK Investigational Site, Meridian
GSK Investigational Site, Tucson
GSK Investigational Site, La Roche-sur-Yon
GSK Investigational Site, Los Angeles
GSK Investigational Site, Buena Park
GSK Investigational Site, San Diego
GSK Investigational Site, Temecula
GSK Investigational Site, Créteil
GSK Investigational Site, Stanford
GSK Investigational Site, Pontoise
GSK Investigational Site, Beijing
GSK Investigational Site, Beijing
GSK Investigational Site, Shanghai
GSK Investigational Site, Yantai
GSK Investigational Site, Qingdao
GSK Investigational Site, Taiyuan
GSK Investigational Site, Wenzhou
GSK Investigational Site, Nanchang
GSK Investigational Site, Wuhan
GSK Investigational Site, Jingzhou
GSK Investigational Site, Dongguan
GSK Investigational Site, Boston
GSK Investigational Site, New Brunswick
GSK Investigational Site, Providence
GSK Investigational Site, Dallas
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Ciudad Autonoma de Bueno
GSK Investigational Site, Florida
GSK Investigational Site, Mendoza
GSK Investigational Site, Rosario
GSK Investigational Site, Hamilton
GSK Investigational Site, London
GSK Investigational Site, Ottawa
GSK Investigational Site, Montreal
GSK Investigational Site, Montreal
GSK Investigational Site, Québec
GSK Investigational Site, Québec
GSK Investigational Site, Dresden
GSK Investigational Site, Dresden
GSK Investigational Site, Ehime
GSK Investigational Site, Ehime
GSK Investigational Site, Fukui
GSK Investigational Site, Fukuoka
GSK Investigational Site, Ishikawa
GSK Investigational Site, Kanagawa
GSK Investigational Site, Kanagawa
GSK Investigational Site, Kumamoto
GSK Investigational Site, Kyoto
GSK Investigational Site, Mie
GSK Investigational Site, Nagano
GSK Investigational Site, Osaka
GSK Investigational Site, Osaka
GSK Investigational Site, Tokyo
GSK Investigational Site, Tokyo
GSK Investigational Site, Amsterdam
GSK Investigational Site, Leiden
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Great Yarmouth
GSK Investigational Site, Stevenage
GSK Investigational Site, Wigan
Lead Sponsor
GlaxoSmithKline
INDUSTRY